Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G - Candel Therapeutics, Inc. | StockGist | StockGist

Companies
CADL
SCHEDULE 13G

Home Top Movers Companies Concepts

Home Filings CADLSCHEDULE 13G

SCHEDULE 13G

Beneficial Ownership

Candel Therapeutics, Inc.

Filed Jan 21, 2026

Accepted Jan 20, 2026, 7:00 PM ET

CIK 0001841387

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Reporting Person

Candel Therapeutics, Inc.

Person Type

HC

CUSIP: 137404109

Recent Filings

Candel Therapeutics, Inc.3 weeks ago

Candel Therapeutics, Inc.3 weeks ago

Candel Therapeutics, Inc.1 months ago

Candel Therapeutics, Inc.1 months ago

Candel Therapeutics, Inc.4 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice